Vivos Therapeutics updates financial calendar with Q2 results release, investor call
VVOS•Q2 2026 results and investor call scheduled
Vivos Therapeutics will release second-quarter 2026 financial results on Aug. 14, 2026, following the market close.
Management will host an investor conference call on Aug. 14, 2026 at 5:00 p.m. ET to discuss results, strategy, and cash burn.
Replay access remains available through Aug. 28, 2026; the webcast will be hosted at https://vivos.com/investors/.
Related News
abrdn Asia-Pacific Income Fund NAV at $5.42 per share as of Aug. 13, 2026
FAX•
Algorhythm net loss from continuing operations widens to $4.15 million in Q2 FY26; net sales more than doubled to $3.01 million
RIME•
